CME

CME Group Inc.

Fundamental data last updated:May 13, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Financial - Data & Stock Exchanges

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

07/22/2026

Business Summary

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

 


Analyze CME on TradingView

VALUATION

P/E

23.93

Market Cap ($M USD)

$102.40B

Forward P/E

18.00

PEG

0.55

PRICE TO SALES

15.15

PRICE TO BOOK

3.81

EV / EBITDA

18.18

5-Year Average P/E

Free Cash Flow Yield

4.23%

DCF Value

$496.92

Graham Number

$140.29

Price to FCF

23.65

EV to FCF

23.89

Earnings Yield

4.18%

FCF Yield

4.23%

DIVIDEND

Yield

3.96%

Annual Payout

$11.20

Payout Ratio

95.77%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$11.81

Next Year EPS Growth Estimate

$15.70

Next Year Revenue Growth Estimate

$867.70B

Return on Equity (ROE)

15.25%

FREE CASH FLOW

Operating Margin

65.57%

Debt-to-Equity

0.13

Piotroski F-Score

7

Altman Z-Score

0.52

Return on Invested Capital (ROIC)

12.31%

Current Ratio

1.02

Quick Ratio

1.02

Net Debt to EBITDA

0.18

Interest Coverage

33.67

Gross Profit margin

86.34%

FCF PER SHARE

$12.05

REVENUE PER SHARE

$18.81

Analyze CME on TradingView

Gainseekers Quantitative Analysis

Summary

CME Group Inc. appears to be significantly undervalued when juxtaposed against its DCF Value and Graham Number, suggesting a potential mispricing by the market. The Forward P/E of 17.95 indicates a more attractive valuation compared to its current P/E, hinting at expected earnings growth. However, the Altman Z-score of 0.52 raises red flags about financial distress, despite a robust Earnings Yield of 4.19%. This paradox of value and risk presents a complex picture, demanding a nuanced approach from investors.

AI Exposure / Tech Reliance

Operating within the Financial - Data & Stock Exchanges industry, CME Group is well-positioned to leverage AI and tech advancements. Its role as a data powerhouse allows it to integrate cutting-edge analytics and machine learning to enhance trading efficiencies. This adaptability ensures resilience in a rapidly evolving tech landscape.

The Bull Case

For the value-driven investor, CME Group offers compelling institutional tailwinds. With an impressive ROIC of 12.31% and a Piotroski F-Score of 7, the company demonstrates strong capital efficiency and financial health. Its operating margin of 65.57% underscores significant pricing power, while a healthy FCF Yield of 4.24% signals robust cash generation. These metrics paint a picture of a company that excels in converting revenue into profit, making it an attractive buy for those seeking growth at a reasonable price.

The Bear Case

Despite its strengths, CME Group faces structural risks that cannot be ignored. The Price/Sales ratio of 15.11 and Price/Book ratio of 3.81 suggest a premium valuation that may not be justified by its current market position. Furthermore, the stock's proximity to its 52-week high, combined with a modest Earnings Surprise of 0.60%, indicates potential overextension. Investors should be wary of these valuation pressures, which could limit upside potential.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Hold

Average Analyst Price Target

$320.25

Institutional Ownership %

1-Year Beta

0.26

Insider Buying % (6 Mo)

Distance to 52-Week High

16.48%

Distance to 52-Week Low

8.99%

EARNINGS SURPRISE %

0.60%

50-DAY SMA

$299.41

200-DAY SMA

$281.99

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.